Safety Rates Drug Report: adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

Drug Injury Quarter

Person who experienced the adverse event (patient)

Event ID	CASEID	CASEVERSION	I F COD	EVENT DT	MFR DT	INIT FDA DT	FDA DT	REPT COD	AUTH NUM	MFR NUM	MFR SNDR	LIT REF	AGE	AGE COD	AGE GRP	GNDR COD	E SUB	WT	WT COD	REPT DT	TO MFR	OCCP COD	REPORTER COUNTRY	OCCR COUNTRY
126901292	12690129	2	F	2016	20160919	20160826	20160927	EXP		US-BAYER-2016-165398	BAYER		63.00	YR	A	M	Y	0.00000		20160927		CN	US	US

Drug(s) used by person

Event ID	CASEID	DRUG SEQ	ROLE COD	DRUGNAME	PROD AI	VAL VBM	ROUTE	DOSE VBM	CUM DOSE CHR	CUM DOSE UNIT	DECHAL	RECHAL	LOT NUM	EXP DT	NDA NUM	DOSE AMT	DOSE UNIT	DOSE FORM	DOSE FREQ
126901292	12690129	1	PS	NEXAVAR	SORAFENIB	1	Oral	400 MG, BID			D				21923	400	MG	FILM-COATED TABLET	BID
126901292	12690129	2	SS	NEXAVAR	SORAFENIB	1	Oral	200 MG, BID			D				21923	200	MG	FILM-COATED TABLET	BID

Indications of drugs used

Event ID	CASEID	INDI DRUG SEQ	INDI PT
126901292	12690129	1	Hepatic cancer
126901292	12690129	2	Hepatocellular carcinoma

Outcome of event

Event ID	CASEID	OUTC COD
126901292	12690129	DE
126901292	12690129	OT

Reactions reported

Event ID	CASEID	PT
126901292	12690129	Asthenia
126901292	12690129	Death
126901292	12690129	Decreased appetite
126901292	12690129	Faeces discoloured
126901292	12690129	Hypotension
126901292	12690129	Nausea

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

no results found

Therapies reported

Event ID	CASEID	DSG DRUG SEQ	START DT	END DT	DUR	DUR COD
126901292	12690129	1	201608		0